January 27, 2016
January 27, 2016 —
In response to low national vaccination rates for the human papillomavirus (HPV), Moores Cancer Center at UC San Diego Health has joined 68 National Cancer Institute (NCI)-designated cancer centers in issuing a statement urging for increased HPV vaccination.
January 26, 2016
January 26, 2016 —
Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence. The mouse study is published January 25 by the Journal of Molecular Medicine.
January 21, 2016
January 21, 2016 —
Patty Maysent has accepted the position as CEO of UC San Diego Health, the region’s only academic health system. Her appointment was approved by the UC Board of Regents and will commence January 21, 2016.
January 20, 2016
January 20, 2016 —
Using a new computer science approach, researchers at University of California, San Diego School of Medicine, Columbia University and Stanford University discovered a distinctive molecular feature — a biomarker — that identified colon cancer patients who were most likely to remain disease-free up to five years after surgery. The biomarker, a protein called CDX2, also helped the researchers identify Stage II colon cancer patients who are most likely to benefit from chemotherapy after surgery.
January 20, 2016
January 20, 2016 —
Researchers at University of California, San Diego School of Medicine and collaborators developed GenomeSpace, a cloud-based, biologist-friendly platform that connects more than 20 bioinformatics software packages and resources for genomic data analysis. The team is now developing and crowdsourcing “recipes” — step-by-step workflows — to better enable non-programming researchers to interpret their genomic data. The work is described in a paper published January 18, 2016 in Nature Methods.
January 14, 2016
January 14, 2016 —
Researchers at University of California, San Diego School of Medicine and Samsara Sciences, Inc., a wholly-owned subsidiary of Organovo Holdings, Inc., have entered into an agreement focused on the development of techniques and methods for the isolation and characterization of liver cells that will help drive new research on liver biology, drug safety and efficacy, and the treatment of liver diseases.
January 14, 2016
January 14, 2016 —
Howard Feldman, MD, FRCP(C), a renowned Canadian neurologist noted for his original research in geriatric cognitive disorders and expertise in large-scale clinical trials, has been named the new director of the Alzheimer’s Disease Cooperative Study (ADCS) at University of California, San Diego, pending approval from the National Institute on Aging (NIA).
January 13, 2016
January 13, 2016 —
Neurosurgeons at UC San Diego Health have initiated a landmark, multi-center study to evaluate how the treatment of brain tumors using the NeuroBlate system, a minimally invasive, FDA-approved laser device, impacts the quality of life of patients.
January 13, 2016
January 13, 2016 —
In the first clinical trial of its type, researchers at University of California, San Diego School of Medicine and the Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
January 13, 2016
January 13, 2016 —
Researchers at University of California, San Diego School of Medicine and Rady Children’s Hospital-San Diego have created the first stem cell-derived in vitro cellular model of a rare, but devastating, neurodegenerative condition called Cockayne syndrome (CS).
